Recent studies have revealed a close association between MS4A3 and tumorigenesis, with significant differences in MS4A3 expression observed in prostate cancer, ovarian cancer, and breast cancer tissues compared with normal tissues (26–29). Here, MS4A3 is linked to ovarian cancer.